AZ, J&J tweaking COVID shots to reduce clotting risks; reportAstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk Share XAZ, J&J tweaking COVID shots to reduce clotting risks; reporthttps://pharmaphorum.com/news/az-jj-covid-vaccine-reduce-clotting-risks/
FDA adds warning of rare neurological side effect to J&J COVID jabThe FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has Share XFDA adds warning of rare neurological side effect to J&J COVID jabhttps://pharmaphorum.com/news/fda-adds-warning-of-rare-neurological-side-effect-to-jj-covid-jab/
Study links AstraZeneca COVID-19 shot to bleeding disorder ITPResearchers in Scotland have identified a possible link between the Oxford University/AstraZeneca COVID-19 and a mostly mild and Share XStudy links AstraZeneca COVID-19 shot to bleeding disorder ITPhttps://pharmaphorum.com/news/study-links-astrazeneca-covid-19-shot-to-bleeding-disorder-itp/
Novartis halts three trials of Beovu eye drug on safety concernsProspects for Novartis’ ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a Share XNovartis halts three trials of Beovu eye drug on safety concernshttps://pharmaphorum.com/news/novartis-halts-three-trials-of-beovu-eye-drug-on-safety-concerns/
Belgium halts dosing of J&J COVID vaccine in under 41s after deathBelgium’s Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson’s Share XBelgium halts dosing of J&J COVID vaccine in under 41s after deathhttps://pharmaphorum.com/news/belgium-halts-dosing-of-jj-covid-vaccine-in-under-41s-after-death/
Safety of mRNA COVID-19 jabs backed, despite myocarditis casesAs US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19 Share XSafety of mRNA COVID-19 jabs backed, despite myocarditis caseshttps://pharmaphorum.com/news/safety-of-mrna-covid-19-jabs-backed-despite-myocarditis-cases/
EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccineA review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of Share XEMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccinehttps://pharmaphorum.com/news/ema-panel-probes-heart-inflammation-with-pfizer-biontech-vaccine/
FDA lifts hold on uniQure gene therapy after cancer case reviewDosing can start once again in uniQure’s phase 3 trial of its haemophilia B gene therapy, after the Share XFDA lifts hold on uniQure gene therapy after cancer case reviewhttps://pharmaphorum.com/news/fda-lifts-hold-on-uniqure-gene-therapy-after-cancer-case-review/
EU safety regulators clear J&J COVID shot despite tiny clot riskThe benefits of Johnson & Johnson’s COVID-19 vaccine outweigh a tiny risk of unusual blood clots forming, Europe’s Share XEU safety regulators clear J&J COVID shot despite tiny clot riskhttps://pharmaphorum.com/news/eu-safety-regulators-clear-jj-covid-shot-despite-tiny-clot-risk/
